These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20723889)
1. Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study. Scarselli G; Bargelli G; Taddei GL; Marchionni M; Peruzzi E; Pieralli A; Mattei A; Buccoliero AM; Fambrini M Fertil Steril; 2011 Jan; 95(1):420-2. PubMed ID: 20723889 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693 [TBL] [Abstract][Full Text] [Related]
3. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671 [TBL] [Abstract][Full Text] [Related]
4. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691 [TBL] [Abstract][Full Text] [Related]
5. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370 [TBL] [Abstract][Full Text] [Related]
6. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system. Kresowik J; Ryan GL; Van Voorhis BJ Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018 [TBL] [Abstract][Full Text] [Related]
7. Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia. Qi X; Zhao W; Duan Y; Li Y Gynecol Obstet Invest; 2008; 65(4):266-8. PubMed ID: 18196936 [TBL] [Abstract][Full Text] [Related]
8. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia. Ewies AA; Alfhaily F Obstet Gynecol Surv; 2012 Nov; 67(11):726-33. PubMed ID: 23151756 [TBL] [Abstract][Full Text] [Related]
9. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study. Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333 [TBL] [Abstract][Full Text] [Related]
10. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review. Buttini MJ; Jordan SJ; Webb PM Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):316-22. PubMed ID: 19566568 [TBL] [Abstract][Full Text] [Related]
11. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device. Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744 [TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hampton NR; Rees MC; Lowe DG; Rauramo I; Barlow D; Guillebaud J Hum Reprod; 2005 Sep; 20(9):2653-60. PubMed ID: 15905289 [TBL] [Abstract][Full Text] [Related]
13. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial. Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Tomas E; Tuppurainen M; Paavonen J BJOG; 2010 Apr; 117(5):602-9. PubMed ID: 20156209 [TBL] [Abstract][Full Text] [Related]
14. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system. Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221 [TBL] [Abstract][Full Text] [Related]
15. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496 [TBL] [Abstract][Full Text] [Related]
16. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia. Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412 [TBL] [Abstract][Full Text] [Related]
17. Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system. Ercan CM; Duru NK; Sakinci M; Alanbay I; Karasahin KE; Baser I Gynecol Endocrinol; 2010 Feb; 26(2):125-8. PubMed ID: 20074021 [TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia. El Behery MM; Saleh HS; Ibrahiem MA; Kamal EM; Kassem GA; Mohamed Mel S Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020 [TBL] [Abstract][Full Text] [Related]
19. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D; Janssens D; Vrijens M; Weyers S Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138 [TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia. Haoula ZJ; Walker KF; Powell MC Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]